Published in J Am Med Dir Assoc on September 20, 2013
Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care (2016) 0.95
'I try not to bother the residents too much' - the use of capillary blood glucose measurements in nursing homes. BMC Nurs (2016) 0.75
A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities. BMJ Open Diabetes Res Care (2015) 0.75
Using a Clinical Surveillance System to Detect Drug-Associated Hypoglycemia in Nursing Home Residents. J Am Geriatr Soc (2015) 0.75
Hyperglycemic crises in adult patients with diabetes. Diabetes Care (2009) 6.01
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care (2007) 4.15
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract (2009) 3.96
Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care (2006) 3.89
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care (2011) 3.06
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2016 EXECUTIVE SUMMARY. Endocr Pract (2016) 3.01
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 2.46
Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med (2006) 2.42
Hyperglycemic crises in diabetes. Diabetes Care (2004) 2.38
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol (2002) 2.14
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes (2004) 2.03
Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care (2010) 1.93
Perioperative glucose control in the diabetic or nondiabetic patient. South Med J (2006) 1.87
Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.85
Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care (2003) 1.61
Primary aldosteronism in diabetic subjects with resistant hypertension. Diabetes Care (2007) 1.60
A double-blind, randomized clinical trial comparing soybean oil-based versus olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med (2012) 1.58
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care (2013) 1.57
Reference data for commonly used sensory and motor nerve conduction studies. Muscle Nerve (2009) 1.57
Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab (2008) 1.56
Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med (2010) 1.51
Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care (2013) 1.51
Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care (2011) 1.42
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES. Endocr Pract (2017) 1.37
Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care (2006) 1.37
Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. Neurourol Urodyn (2010) 1.36
In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology (2008) 1.34
Tryptophan catabolism and T cell responses. Adv Exp Med Biol (2003) 1.34
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19
Evidence for strict inpatient blood glucose control: time to revise glycemic goals in hospitalized patients. Metabolism (2008) 1.18
Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care (2009) 1.18
Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes (2009) 1.17
Sliding scale insulin use: myth or insanity? Am J Med (2007) 1.17
Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest (2005) 1.16
Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.15
Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care (2009) 1.14
Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am (2012) 1.04
Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures. PLoS One (2010) 1.04
Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care (2013) 1.04
Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care (2009) 1.02
Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem Biophys Res Commun (2004) 1.02
Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Diabetes Manag (Lond) (2011) 1.00
Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care (2013) 1.00
Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab (2011) 1.00
Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol (2012) 1.00
The use of alkali therapy in severe diabetic ketoacidosis. Diabetes Care (2002) 0.99
Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab (2010) 0.99
Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg (2015) 0.99
Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling. Endocr Pract (2007) 0.97
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS. Endocr Pract (2016) 0.97
Breast abscesses in nonlactating women with diabetes: clinical features and outcome. Am J Med Sci (2009) 0.96
Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma. J Am Coll Surg (2010) 0.96
Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosis. J Crit Care (2002) 0.95
Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am J Physiol Endocrinol Metab (2004) 0.93
Incunabular immunological events in prion trafficking. Sci Rep (2012) 0.93
Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci (2010) 0.92
Quantile regression for left-truncated semicompeting risks data. Biometrics (2010) 0.91
Substitution of standard soybean oil with olive oil-based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab (2011) 0.91
The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes. Transl Res (2012) 0.91
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial. Diabetes Care (2015) 0.91
Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes. Diabetes Care (2009) 0.91
Flexible modeling of longitudinal highly skewed outcomes. Stat Med (2009) 0.90
A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med (2010) 0.90
Genetic depletion of complement receptors CD21/35 prevents terminal prion disease in a mouse model of chronic wasting disease. J Immunol (2012) 0.90
Changes in serum leptin in lean and obese subjects with acute hyperglycemic crises. J Clin Endocrinol Metab (2003) 0.90
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract (2017) 0.90
Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Diabetes Care (2010) 0.89
Accelerated Recurrence Time Models. Scand Stat Theory Appl (2009) 0.89
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89
A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int (2009) 0.89
Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy. Endocr Pract (2013) 0.87